|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 65.86 USD | -27.31% |
|
-.--% | - |
| 05-13 | Spanish stocks - Factors to watch on May 13 | RE |
| 05-09 | Laboratorios Farmaceuticos Rovi, S.A., Q1 2026 Earnings Call, May 06, 2026 |
Performance
| 1 day | -27.31% | ||
| 3 years | +28.89% | ||
| 5 years | -2.82% |
Volumes
marketsDaily volume
200
Estimated daily volume
1,282
Record volume 1
2,509
Record volume 2
938
Record volume 3
815
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
3,421,558,375
Net sales (EUR)
743,483,000
Net sales (USD)
856,744,642
Number of employees
1,998
Sales / Employee (EUR)
372,114
Sales / Employee (USD)
428,801
Free-Float
31.63 %
Free-Float capitalization (USD)
1,084,213,523
Indicators
STIM
RSI 9 days
0
RSI 14 days
0
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -27.31% | -.--% | -.--% | +28.89% | 3.42B | |
| -0.79% | +1.41% | +41.30% | +157.66% | 1,035B | |
| -0.09% | +2.19% | +51.84% | +48.76% | 574B | |
| -0.05% | -0.76% | +17.19% | +63.73% | 397B | |
| +0.41% | +0.77% | +21.19% | +15.95% | 324B | |
| -0.60% | -2.83% | +22.09% | +13.83% | 281B | |
| +0.57% | +3.58% | +24.60% | +34.52% | 278B | |
| +1.28% | +5.29% | -44.84% | -47.64% | 193B | |
| -0.07% | +0.94% | +18.69% | +62.34% | 191B | |
| -1.12% | -3.62% | +11.09% | +59.88% | 156B | |
| Average | -2.77% | +1.68% | +16.32% | +43.79% | 343.34B | |
| Weighted average by Cap. | -0.22% | +2.39% | +27.93% | +72.04% |
Historical Quotes: Laboratorios Farmaceuticos Rovi, S.A.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Course Extremes
| 3 years | 50.88 |  | 90.61 |
| 5 years | 0.03 | | 90.61 |
| 10 years | 0.03 | | 90.61 |
Monthly variations
Annual variations
| 2024 | +26.66% | ||
| 2023 | +1.76% | ||
| 2022 | -25.67% | ||
| 2021 | +26.03% |
- Stock Market
- Stocks
- ROVI Stock
- LABF.F Stock
- Quotes Laboratorios Farmaceuticos Rovi, S.A.
Select your edition
All financial news and data tailored to specific country editions
